Diagnostic tools in tuberculosis. Present and future

Respiration

Volumn 65, Issue 3, 1998, Pages 163-170

  Salfinger, Max ^a,b   Hale, Yvonne M ^c   Driscoll, Jeffrey R ^a  

^a WADSWORTH CENTER   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c FLORIDA DEPARTMENT OF HEALTH   (United States)

Author keywords

Drug resistance; Laboratory service; Microscopy; Mycobacterium; Nucleic acid amplification; Public health; Tuberculosis

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC TEST; GENE AMPLIFICATION; HUMAN; LABORATORY TEST; LUNG TUBERCULOSIS; MALE; MOLECULAR BIOLOGY; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID PROBE; PRIORITY JOURNAL; TUBERCULIN TEST;

ADULT; CONTACT TRACING; DNA PROBES; FATAL OUTCOME; GENE AMPLIFICATION; HUMANS; LABORATORIES; MALE; MICROBIAL SENSITIVITY TESTS; SPECIMEN HANDLING; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 0031812610     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029252     Document Type: Article

References (25)

1. Salfinger M, Pfyffer GE: The new diagnostic mycobacteriology laboratory. Eur J Clin Microbiol Infect Dis 1994;11:961-979.
2. Salfinger M, Fitzgerald MJ, Taber HW, DiFerdinando GT: How rapidly do New York State tuberculosis laboratories report drug susceptibility testing results to physicians? International Conference, American Thoracic Society, New Orleans, LA, May 11-15, 1996.
3. Centers for Disease Control and Prevention: Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities. Morb Mortal Wkly Rep 1994;43:1-32.
4. ATS Statement [Catanzaro A, Davidson B, Fujiwara P, Goldberger MJ, Gordin F, Salfinger M, Sbarbaro J, Schluger NW, Sierra MF, Woods GL]: Rapid diagnostic tests for tuberculosis. What is the appropriate role? Am J Respir Crit Care Med 1997;155:1804-1814.
5. Pfyffer GE, Kissling P, Jahn EM, Welscher H, Salfinger M, Weber R: Diagnostic performance of Amplified Mycobacterium tuberculosis Direct Test with cerebrospinal fluid, other non-respiratory, and respiratory specimens. J Clin Microbiol 1996;34:834-841.
6. Nolte FS, Metchock B: Mycobacterium; in Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds): Manual of Clinical Microbiology, ed 6. American Society for Microbiology, Washington, 1995, pp 400-437.
7. Floyd MM, Silcox VA, Jones WD, Butler WR, Kilburn JO: Separation of Mycobacterium bovis BCG from Mycobacterium tuberculosis and Mycobacterium bovis by using high-performance liquid chromatography of mycolic acids. J Clin Microbiol 1992;30:1327-1330.
8. Parsons LM, Driscoll JR, Taber HW, Salfinger M: Drug resistance in mycobacteria. Infect Dis Clin N Am 1997;11:905-928.
9. Mitchison DA, Nunn AJ: Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis 1986;133:423-430.
10. Inderlied CB, Salfinger M: Antimicrobial agents and susceptibility tests: Mycobacteria; in Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds): Manual of Clinical Microbiology, ed 6. Washington, American Society for Microbiology, 1995, pp 1385-1404.
11. Telenti A, Honore N, Bernasconi C, March J, Onega A, Heym B, Takiff HE, Cole ST: Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: A blind study at reference laboratory level. J Clin Microbiol 1997;35:719-723.
12. Hopewell PC, Small P: Applications of molecular epidemiology to the prevention, control, and study of tuberculosis: in Rom WN, Garay SM (eds): Tuberculosis. Boston, Little, Brown, 1996, pp 113-127.
13. Jovell RJ, Salfinger M: Molecular fingerprinting of Mycobacterium tuberculosis: A new tool enhancing tuberculosis control programs. RT J Respir Care Practitioners 1996;April/May: p 66ff.
14. American Thoracic Society: Levels of laboratory services for mycobacterial diseases: Official Statement of the American Thoracic Society. Am Rev Respir Dis 1983;128:213.
15. MacGregor RR, Clark LW, Bass F: The significance of isolating low numbers of Mycobacterium tuberculosis in culture of sputum specimens. Chest 1975;68:518-523.
16. Nitta AT, Davidson PT, de Koning ML, Kilman RJ: Misdiagnosis of multidrug-resistant tuberculosis possibly due to laboratory-related errors. JAMA 1996;276:1980-1983.
17. Gubler JGH, Salfinger M, von Graevenitz A: Pseudoepidemic of nontuberculous mycobacteria due to a contaminated bronchoscope cleaning machine - report of an outbreak and review of the literature. Chest 1992;101:1245-1249.
18. Kaul K, Luke S, McGurn C, Snowden N, Monti C, Fry WA: Amplification of residual DNA sequences in sterile bronchoscopes leading to false-positive PCR results. J Clin Microbiol 1996;34:1949-1951.
19. Dunlap NE, Harris RH, Benjamin WH, Harden JW, Hafner D: Laboratory contamination of Mycobacterium tuberculosis cultures. Am J Respir Crit Care Med 1995;152:1702-1704.
20. Yuen KY, Yam WC, Wong LP, Seto WH: Comparison of two automated DNA amplification systems with a manual one-tube nested PCR assay for diagnosis of pulmonary tuberculosis. J Clin Microbiol 1997;35:1385-1389.
21. Hoheisel JD: Oligomer-chip technology. Trends Biotechnol 1997;15:465-469.
22. Kozal M, Shah N, Shen N, Fucini R, Yang R, Merigan T, Richman DD, Morris MS, Hubbell E, Chee M, Gingeras TR: Extensive polymorphisms observed in HIV-1 clade B protease gene using high density oligonucleotide arrays: Implications for therapy. Nature Med 1996;7: 753-759.
23. Fodor SP, Rava RP, Huang XC, Pease AC, Holmes CP, Adams CL: Multiplexed biochemical assays with biological chips. Nature 1993; 364:555-556.
24. Pease AC, Solas D, Sullivan EJ, Cronin MT, Holmes CP, Fodor SP: Light-generated oligonucleotide arrays for rapid DNA sequence analysis. Proc Natl Acad Sci USA 1994;91: 5022-5026.
25. Wallace RW: DNA on a chip: Serving up the genome for diagnostics and research. Mol Med Today 1997;September:384-388.